CollPlant Biotechnologies (CLGN) Profit After Tax (2017 - 2026)

CollPlant Biotechnologies (CLGN) has 10 years of Profit After Tax data on file, last reported at -$3.1 million in Q1 2026.

• Quarterly Profit After Tax fell 313.29% year-over-year to -$3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.0 million (down 158.49% YoY) and the FY2025 annual result came in at -$11.5 million, down 169.17% from the prior year.
• Profit After Tax improved to -$3.1 million in Q1 2026, from -$19.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $29.3 million in Q4 2024 to a low of -$19.8 million in Q4 2025.
• A 5-year average of $919705.9 and a median of $3.3 million in 2025 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2024 — Profit After Tax soared 413.83% — and 2026, when it sank 313.29%.
• Tracing CLGN's Profit After Tax over 5 years: stood at -$4.4 million in 2022, then slumped by 112.43% to -$9.3 million in 2023, then soared by 413.83% to $29.3 million in 2024, then tumbled by 167.39% to -$19.8 million in 2025, then soared by 84.34% to -$3.1 million in 2026.
• The last three Profit After Tax figures came in at -$3.1 million (Q1 2026), -$19.8 million (Q4 2025), and -$3.5 million (Q3 2025), per Business Quant data.